Prudential Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.25M | Sell |
62,875
-10,370
| -14% | -$528K | ﹤0.01% | 1102 |
|
|
2025
Q4 | $3.64M | Sell |
73,245
-34,353
| -32% | -$1.67M | ﹤0.01% | 1044 |
|
|
2025
Q3 | $5.14M | Buy |
107,598
+5,480
| +5% | +$221K | 0.01% | 929 |
|
|
2025
Q2 | $3.62M | Buy |
102,118
+11,035
| +12% | +$354K | ﹤0.01% | 1091 |
|
|
2025
Q1 | $3.24M | Buy |
91,083
+24,350
| +36% | +$863K | ﹤0.01% | 1048 |
|
|
2024
Q4 | $2.37M | Buy |
66,733
+8,352
| +14% | +$294K | ﹤0.01% | 1223 |
|
|
2024
Q3 | $1.82M | Sell |
58,381
-1,325
| -2% | -$41.4K | ﹤0.01% | 1548 |
|
|
2024
Q2 | $1.6M | Sell |
59,706
-2,124
| -3% | -$61.6K | ﹤0.01% | 1551 |
|
|
2024
Q1 | $2.11M | Sell |
61,830
-1,814
| -3% | -$54K | ﹤0.01% | 1422 |
|
|
2023
Q4 | $1.84M | Sell |
63,644
-1,405
| -2% | -$37.3K | ﹤0.01% | 1488 |
|
|
2023
Q3 | $1.79M | Sell |
65,049
-3,285
| -5% | -$100K | ﹤0.01% | 1447 |
|
|
2023
Q2 | $2.05M | Buy |
68,334
+14,505
| +27% | +$508K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $1.95M | Sell |
53,829
-1,574
| -3% | -$60.5K | ﹤0.01% | 1361 |
|
|
2022
Q4 | $1.98M | Sell |
55,403
-75
| -0.1% | -$2.61K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $1.85M | Sell |
55,478
-3,971
| -7% | -$129K | ﹤0.01% | 1374 |
|
|
2022
Q2 | $1.7M | Sell |
59,449
-891
| -1% | -$25.5K | ﹤0.01% | 1483 |
|
|
2022
Q1 | $1.95M | Sell |
60,340
-25,487
| -30% | -$781K | ﹤0.01% | 1507 |
|
|
2021
Q4 | $2.51M | Sell |
85,827
-93,420
| -52% | -$2.83M | ﹤0.01% | 1404 |
|
|
2021
Q3 | $4.89M | Buy |
179,247
+74,200
| +71% | +$1.99M | 0.01% | 998 |
|
|
2021
Q2 | $3.23M | Buy |
105,047
+12,952
| +14% | +$397K | ﹤0.01% | 1245 |
|
|
2021
Q1 | $2.41M | Sell |
92,095
-422,358
| -82% | -$11.8M | ﹤0.01% | 1364 |
|
|
2020
Q4 | $12.9M | Sell |
514,453
-137,769
| -21% | -$2.97M | 0.02% | 637 |
|
|
2020
Q3 | $13.6M | Buy |
652,222
+34,366
| +6% | +$780K | 0.03% | 541 |
|
|
2020
Q2 | $14.7M | Buy |
617,856
+230,596
| +60% | +$5.09M | 0.03% | 544 |
|
|
2020
Q1 | $6.97M | Sell |
387,260
-145,571
| -27% | -$3.06M | 0.02% | 785 |
|
|
2019
Q4 | $12.6M | Buy |
532,831
+217,408
| +69% | +$5.28M | 0.02% | 762 |
|
|
2019
Q3 | $8.67M | Buy |
315,423
+226,744
| +256% | +$6.72M | 0.01% | 894 |
|
|
2019
Q2 | $2.94M | Sell |
88,679
-36,773
| -29% | -$1.26M | ﹤0.01% | 1402 |
|
|
2019
Q1 | $4.4M | Buy |
125,452
+1,502
| +1% | +$55.9K | 0.01% | 1190 |
|
|
2018
Q4 | $4.12M | Sell |
123,950
-2,050
| -2% | -$88.2K | 0.01% | 1176 |
|
|
2018
Q3 | $6.34M | Sell |
126,000
-302,458
| -71% | -$14.9M | 0.01% | 1084 |
|
|
2018
Q2 | $25.6M | Buy |
428,458
+27,880
| +7% | +$1.44M | 0.04% | 523 |
|
|
2018
Q1 | $18.3M | Buy |
400,578
+3,833
| +1% | +$160K | 0.03% | 640 |
|
|
2017
Q4 | $15.8M | Sell |
396,745
-8,225
| -2% | -$325K | 0.02% | 736 |
|
|
2017
Q3 | $16.2M | Sell |
404,970
-32,170
| -7% | -$1.39M | 0.02% | 713 |
|
|
2017
Q2 | $18.8M | Buy |
437,140
+211,950
| +94% | +$7.54M | 0.03% | 631 |
|
|
2017
Q1 | $7.05M | Sell |
225,190
-48,409
| -18% | -$1.3M | 0.01% | 986 |
|
|
2016
Q4 | $6.91M | Buy |
273,599
+18,653
| +7% | +$417K | 0.01% | 986 |
|
|
2016
Q3 | $6.3M | Buy |
254,946
+57,290
| +29% | +$1.3M | 0.01% | 978 |
|
|
2016
Q2 | $4.03M | Buy |
197,656
+104,140
| +111% | +$1.85M | 0.01% | 1223 |
|
|
2016
Q1 | $1.43M | Sell |
93,516
-24,592
| -21% | -$321K | ﹤0.01% | 1690 |
|
|
2015
Q4 | $1.59M | Buy |
118,108
+3,457
| +3% | +$53.5K | ﹤0.01% | 1607 |
|
|
2015
Q3 | $1.61M | Sell |
114,651
-64,000
| -36% | -$1.19M | ﹤0.01% | 1556 |
|
|
2015
Q2 | $3.03M | Buy |
178,651
+165,651
| +1,274% | +$2.36M | 0.01% | 1353 |
|
|
2015
Q1 | $157K | Buy |
+13,000
| New | +$123K | ﹤0.01% | 2160 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Prudential Financial's SUPN Position: Q1 2026 in Review
Prudential Financial reduced its Supernus Pharmaceuticals (SUPN) stake by 14% in Q1 2026, selling an estimated $528K and leaving 62,875 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.
Prudential Financial first reported a position in SUPN in Q1 2015 and has held it in 45 quarters since. The position peaked at $25.6M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Prudential Financial held 62,875 shares of Supernus Pharmaceuticals worth $3.25M as of Q1 2026.
- Prudential Financial sold 10,370 Supernus Pharmaceuticals shares in Q1 2026, an estimated $528K.
- Supernus Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1102 holding.
- Prudential Financial first reported a position in Supernus Pharmaceuticals in Q1 2015 and has held it in 45 quarters since.
- Prudential Financial's Supernus Pharmaceuticals position peaked at $25.6M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.